Skip to main content

Peer Review reports

From: Propranolol restores susceptibility of XDR Gram-negative pathogens to meropenem and Meropenem combination has been evaluated with either tigecycline or amikacin

Original Submission
3 Mar 2023 Submitted Original manuscript
9 Apr 2023 Reviewed Reviewer Report
17 Apr 2023 Reviewed Reviewer Report
25 Apr 2023 Author responded Author comments - Khaled M. Aboshanab
18 May 2023 Reviewed Reviewer Report
28 May 2023 Reviewed Reviewer Report
2 Jun 2023 Author responded Author comments - Khaled M. Aboshanab
Resubmission - Version 2
25 Apr 2023 Submitted Manuscript version 2
2 Jun 2023 Author responded Author comments - Khaled M. Aboshanab
Resubmission - Version 3
2 Jun 2023 Submitted Manuscript version 3
12 Jun 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
4 Jul 2023 Editorially accepted
22 Jul 2023 Article published 10.1186/s12866-023-02934-6

You can find further information about peer review here.

Back to article page